MedPath

effect of probiotic supplements on epilepsy

Phase 2
Conditions
epilepsy.
Epilepsy and recurrent seizures
Registration Number
IRCT20161230031668N4
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Patients with drug-resistant epilepsy
Treated with anticonvulsant drugs for at least two months before entering the study
At least two seizures in the last week
Informed parental consent to participate in the study

Exclusion Criteria

Systemic disorder such as immune deficiency
Heart disease, kidney disease, endocrine diseases, digestive and liver diseases and hereditary metabolic disorders
treatment with probiotics in the 30 days before to the inclusion in the study
participating in anyother epilepsy-related study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The number of attacks per month. Timepoint: Every week for a month. Method of measurement: Parental report.;The duration of each attack. Timepoint: Every week for a month. Method of measurement: Parental report.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath